![The FDA-approved Brijjit BP100 is a groundbreaking medical device that revolutionizes healing across all stages - from wound closure to support and scar therapy. Clinically proven to reduce wound breakdown by 90% and scar mean area by 38%, it offers enhanced control and confidence at every step of the healing journey.](https://www.finsmes.com/wp-content/uploads/2024/02/image-20.jpeg)
BRIJ Medical, a Marietta, GA-based medical device manufacturer, raised $5.5M in funding.
The round was led by Tim Gleeson (Vidant Capital) and a list of MedTech industry veterans.
The company intends to use the funds for further product development and commercial rollout of its incision and scar management system.
Led by Felmont “Monte” Eaves, MD, founder and Chief Medical Officer, BRIJ Medical also launched its strategic rebrand from Brijjit Medical to BRIJ Medical and is introducing new technologies designed to minimize wound complications and improve scar therapy. The FDA-approved Brijjit BP100 is a medical device that revolutionizes healing across all stages – from wound closure to support and scar therapy.
FinSMEs
12/02/2024